Gastroparesis natural and alternative therapy
September 24 2015
Gastroparesis is often a manifestation of diabetic autonomic neuropathy.
It may be related to a variety of underlying disorders, but diabetes
mellitus is by far the most common cause. Gastrointestinal autonomic neuropathy contributes to morbidity, mortality,
reduced quality of life, and increased healthcare costs of a patient with
diabetes mellitus. Complications from gastroparesis include ketoacidosis,
infection, and bezoar formation. Gastric
electrical stimulation has recently emerged as an effective strategy in the
management of these patients.
Concern over pharmaceuticals has set an increased population seeking natural alternatives for their digestive health issues.
Natural treatment, therapy
Apple cider vinegar has been tested.
Alpha lipoic acid may be of benefit in diabetes induced gastroparesis since alpha lipoic acid helps nerve function in diabetics.
Symptoms and signs
Symptoms of gastroparesis include early satiety, postprandial bloating, nausea and vomiting. Patients with gastroparesis can be frustrated with the symptoms they experience, the intensive treatment regimens they must follow, as well as the medical procedures they undergo during the course of their treatment. Quality of life is an important factor to consider when caring for and supporting these patients.
In general, treatment involves dietary and lifestyle adjustment as well as pharmacological interventions. Some patients with severe nausea and vomiting will require antiemetic medications. Treatment includes dietary changes (low-fiber and low-residue diets, and in some cases, restrictions on fat and/or solids), oral medications such as metoclopramide (Reglan, Maxolon, Clopra).
Clin Exp Gastroenterol. 2013. Gastroparesis: a review of current and emerging treatment options. Gastroparesis is a motility disorder of the stomach causing delay in food emptying from the stomach without any evidence of mechanical obstruction. The majority of cases are idiopathic. Patients need to be diagnosed properly by formal testing, and the evaluation of the severity of the gastroparesis may assist in guiding therapy. Initially, dietary modifications are encouraged, which include frequent and small semisolid-based meals. Promotility medications, like erythromycin, and antiemetics, like prochlorperazine, are offered for symptom relief. In patients who are refractory to pharmacologic treatment, more invasive options, such as intrapyloric botulinum toxin injections, placement of a jejunostomy tube, or implantation of a gastric stimulator, can be considered. Hemin therapy and gastric electric stimulation are emerging treatment options that are still at different stages of research. Regenerative medicine and stem cell-based therapies also hold promise for gastroparesis in the near future.